Currently, only two facilities are open for patient enrollment in the clinical trial: Shephard Center in Atlanta, Ga., and Northwestern Memorial Hospital in Chicago. Patients interested in participating in the trial will undergo tremendously strict selection processes, and in the end, only eight will participate.
The trial is sponsored by Geron Corp., a biopharmaceutical company, which has the first U.S. FDA license to use embryonic stem cells to treat people. More specifically, Geron is using the stem cells on patients with new spinal cord injuries.
Read the Reuters report about Northwestern’s stem cell trial.
Read more about Northwestern Memorial Hospital:
–Chicago Area Hospitals Prepare for Rulings on Tax-Exempt Status
–Northwestern Memorial Hospital, Physicians to Become Northwestern Medicine
–Hospital Leader to Know: Dean Harrison of Northwestern Memorial Healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
